BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 17023678)

  • 1. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study.
    Smith FB; Lee AJ; Hau CM; Rumley A; Lowe GD; Fowkes FG
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):43-50. PubMed ID: 10691098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
    Sinning JM; Bickel C; Messow CM; Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Lackner KJ; Tiret L; Münzel T; Blankenberg S;
    Eur Heart J; 2006 Dec; 27(24):2962-8. PubMed ID: 17132649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
    N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
    Oda H; Ohno M; Ohashi H
    Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.
    van der Bom JG; Bots ML; Haverkate F; Meijer P; Hofman A; Kluft C; Grobbee DE
    Thromb Haemost; 2001 Feb; 85(2):234-9. PubMed ID: 11246539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
    Kirmizis D; Tsiandoulas A; Pangalou M; Koutoupa E; Rozi P; Protopappa M; Barboutis K
    Med Sci Monit; 2006 Feb; 12(2):CR55-62. PubMed ID: 16449948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
    Lee KW; Blann AD; Lip GY
    Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease.
    Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
    Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):171-6. PubMed ID: 15649725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Price JF; Smith FB; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Am J Epidemiol; 2006 Feb; 163(4):334-41. PubMed ID: 16357107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease.
    Rallidis LS; Varounis C; Sourides V; Charalampopoulos A; Kotakos C; Liakos G; Dagres N; Apostolou T; Anastasiou-Nana M
    Curr Med Res Opin; 2011 Jul; 27(7):1407-13. PubMed ID: 21568834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
    Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
    J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardiovascular risk factors.
    Giansante C; Fiotti N; Cattin L; Da Col PG; Calabrese S
    Thromb Haemost; 1994 May; 71(5):581-6. PubMed ID: 8091384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemostatic and fibrinolytic factors in men with a small abdominal aortic aneurysm.
    Parry DJ; Al-Barjas HS; Chappell L; Rashid T; Ariëns RA; Scott DJ
    Br J Surg; 2009 Aug; 96(8):870-7. PubMed ID: 19591171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-dimers, thrombin-antithrombin complexes, and risk factors for thromboembolism in hospitalized patient.
    Pottier P; Fouassier M; Hardouin JB; Volteau C; Planchon B
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):666-75. PubMed ID: 18796458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies.
    Lowe GD; Sweetnam PM; Yarnell JW; Rumley A; Rumley C; Bainton D; Ben-Shlomo Y
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1957-62. PubMed ID: 15308549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Circulation; 2007 Apr; 115(16):2119-27. PubMed ID: 17404162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of D-Dimers and fibrinogen plasma determination in patients with polyvascular disease.
    Bosevski M; Kostoska S; Tosev S; Borozanov V
    Angiol Sosud Khir; 2006; 12(2):9-15. PubMed ID: 17053757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
    Cavusoglu Y; Gorenek B; Alpsoy S; Unalir A; Ata N; Timuralp B
    Isr Med Assoc J; 2001 Jan; 3(1):13-6. PubMed ID: 11344793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.